Sigma Planning Corp’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
15,028
+1,269
+9% +$97.8K 0.03% 542
2025
Q4
$1.09M Buy
13,759
+863
+7% +$68K 0.03% 504
2025
Q3
$972K Buy
12,896
+1,600
+14% +$110K 0.03% 540
2025
Q2
$779K Sell
11,296
-4,786
-30% -$314K 0.02% 592
2025
Q1
$1.09M Sell
16,082
-6,320
-28% -$378K 0.03% 466
2024
Q4
$1.01M Sell
22,402
-2,384
-10% -$134K 0.03% 484
2024
Q3
$1.56M Sell
24,786
-13,100
-35% -$764K 0.05% 365
2024
Q2
$2.24M Sell
37,886
-11,090
-23% -$694K 0.07% 262
2024
Q1
$3.91M Buy
48,976
+26,611
+119% +$2.03M 0.12% 169
2023
Q4
$1.77M Sell
22,365
-35,612
-61% -$2.53M 0.14% 156
2023
Q3
$4.05M Buy
57,977
+1,856
+3% +$132K 0.15% 138
2023
Q2
$3.88M Sell
56,121
-7,259
-11% -$517K 0.14% 147
2023
Q1
$4.71M Buy
63,380
+5,013
+9% +$420K 0.16% 135
2022
Q4
$5.44M Sell
58,367
-805
-1% -$77.7K 0.19% 119
2022
Q3
$5.64M Sell
59,172
-2,867
-5% -$284K 0.22% 103
2022
Q2
$5.75M Buy
62,039
+3,427
+6% +$334K 0.2% 111
2022
Q1
$5.93M Buy
58,612
+702
+1% +$73.7K 0.18% 114
2021
Q4
$5.97M Buy
57,910
+2,465
+4% +$228K 0.17% 121
2021
Q3
$4.71M Sell
55,445
-1,704
-3% -$143K 0.14% 158
2021
Q2
$4.77M Sell
57,149
-6,813
-11% -$558K 0.14% 154
2021
Q1
$4.81M Buy
63,962
+731
+1% +$53.2K 0.15% 155
2020
Q4
$4.32M Sell
63,231
-1,806
-3% -$117K 0.15% 153
2020
Q3
$3.8M Buy
65,037
+4,114
+7% +$256K 0.15% 151
2020
Q2
$3.96M Buy
60,923
+1,103
+2% +$69.5K 0.17% 129
2020
Q1
$3.55M Sell
59,820
-2,277
-4% -$152K 0.21% 102
2019
Q4
$4.61M Sell
62,097
-3,597
-5% -$253K 0.19% 115
2019
Q3
$4.14M Buy
65,694
+7,280
+12% +$431K 0.2% 121
2019
Q2
$3.18M Buy
58,414
+8,987
+18% +$484K 0.16% 153
2019
Q1
$2.67M Buy
49,427
+11,596
+31% +$716K 0.15% 156
2018
Q4
$2.48M Buy
37,831
+6,761
+22% +$505K 0.18% 120
2018
Q3
$2.45M Sell
31,070
-606
-2% -$43.3K 0.14% 152
2018
Q2
$2.04M Buy
31,676
+3,021
+11% +$199K 0.14% 175
2018
Q1
$1.78M Buy
28,655
+2,077
+8% +$149K 0.13% 179
2017
Q4
$1.93M Buy
26,578
+64
+0.2% +$4.65K 0.15% 173
2017
Q3
$2.16M Buy
26,514
+6,963
+36% +$551K 0.18% 143
2017
Q2
$1.57M Buy
19,551
+126
+0.6% +$9.95K 0.15% 170
2017
Q1
$1.52M Buy
19,425
+1,882
+11% +$150K 0.15% 169
2016
Q4
$1.38M Buy
17,543
+2,569
+17% +$208K 0.15% 161
2016
Q3
$1.33M Sell
14,974
-733
-5% -$69.2K 0.16% 155
2016
Q2
$1.5M Buy
15,707
+777
+5% +$77.4K 0.2% 123
2016
Q1
$1.55M Buy
14,930
+1,739
+13% +$169K 0.21% 109
2015
Q4
$1.29M Buy
13,191
+220
+2% +$21.5K 0.18% 128
2015
Q3
$1.25M Sell
12,971
-158
-1% -$16.6K 0.2% 119
2015
Q2
$1.38M Sell
13,129
-2,250
-15% -$230K 0.19% 139
2015
Q1
$1.59M Sell
15,379
-3,350
-18% -$339K 0.21% 125
2014
Q4
$1.8M Buy
+18,729
New +$1.65M 0.24% 106

Other funds holding CVS

Sigma Planning Corp's CVS Position: Q1 2026 in Review

Sigma Planning Corp increased its CVS Health (CVS) stake by 9.2% in Q1 2026, buying an estimated $97.8K and bringing the position to 15,028 shares worth $1.08M. The position accounts for 0.03% of the portfolio, ranked #542.

Sigma Planning Corp first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.97M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Sigma Planning Corp held 15,028 shares of CVS Health worth $1.08M as of Q1 2026.
  • Sigma Planning Corp bought 1,269 CVS Health shares in Q1 2026, an estimated $97.8K.
  • CVS Health made up 0.03% of Sigma Planning Corp's portfolio in Q1 2026, its #542 holding.
  • Sigma Planning Corp first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
  • Sigma Planning Corp's CVS Health position peaked at $5.97M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Sigma Planning Corp's 13F filing for Q1 2026, filed 4 May 2026.